146 related articles for article (PubMed ID: 1830222)
1. Enoximone as a bridge to heart transplantation: the Utah experience.
O'Connell JB; Gilbert EM; Renlund DG; Bristow MR
J Heart Lung Transplant; 1991; 10(3):477-81. PubMed ID: 1830222
[TBL] [Abstract][Full Text] [Related]
2. Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors.
Lee HR; Hershberger RE; Port JD; Rasmussen R; Renlund DG; O'Connell JB; Gilbert EM; Mealey PC; Volkman K; Menlove R
J Thorac Cardiovasc Surg; 1991 Aug; 102(2):246-58. PubMed ID: 1650867
[TBL] [Abstract][Full Text] [Related]
3. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
Weber KT; Janicki JS; Jain MC
J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397
[TBL] [Abstract][Full Text] [Related]
4. [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone].
Holubarsch C; Hasenfuss G; Thierfelder L; Heiss HW; Just H
Z Kardiol; 1991; 80 Suppl 4():35-40. PubMed ID: 1833895
[TBL] [Abstract][Full Text] [Related]
5. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
Uretsky BF; Valdes AM; Reddy PS
Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328
[TBL] [Abstract][Full Text] [Related]
6. [Hemodynamic effects of enoximone--comparative studies of heart surgery patients].
Boldt J; Hempelmann G
Z Kardiol; 1991; 80 Suppl 4():41-6. PubMed ID: 1833896
[TBL] [Abstract][Full Text] [Related]
7. [Enoximone as an alternative to mechanical circulatory support prior to heart transplantation].
Schmid ER; Zollinger A; Turina M; Dieterich HA
Schweiz Med Wochenschr; 1989 Sep; 119(36):1231-6. PubMed ID: 2529633
[TBL] [Abstract][Full Text] [Related]
8. [Enoximone].
Ventura G
Medicina (Firenze); 1990; 10(2):191-3. PubMed ID: 2148796
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of the enoximone clinical trials program.
Lowes BD; Shakar SF; Metra M; Feldman AM; Eichhorn E; Freytag JW; Gerber MJ; Liard JF; Hartman C; Gorczynski R; Evans G; Linseman JV; Stewart J; Robertson AD; Roecker EB; Demets DL; Bristow MR
J Card Fail; 2005 Dec; 11(9):659-69. PubMed ID: 16360960
[TBL] [Abstract][Full Text] [Related]
10. Perioperative mechanical circulatory support for transplantation.
Marks JD; Karwande SV; Richenbacher WE; Jones KW; Doty DB; Millar RC; O'Connell JB; Renlund DG; Bristow MR; Pantalos GM
J Heart Lung Transplant; 1992; 11(1 Pt 1):117-28. PubMed ID: 1531769
[TBL] [Abstract][Full Text] [Related]
11. Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial.
Feldman AM; Oren RM; Abraham WT; Boehmer JP; Carson PE; Eichhorn E; Gilbert EM; Kao A; Leier CV; Lowes BD; Mathier MA; McGrew FA; Metra M; Zisman LS; Shakar SF; Krueger SK; Robertson AD; White BG; Gerber MJ; Wold GE; Bristow MR;
Am Heart J; 2007 Nov; 154(5):861-9. PubMed ID: 17967591
[TBL] [Abstract][Full Text] [Related]
12. [Use of a new inotropic agent, enoximone, in heart surgery].
Gomar C; Fita G; Pomar JL; Valero R; Mulet J; Nalda MA
Rev Esp Anestesiol Reanim; 1991; 38(2):121-6. PubMed ID: 1678896
[TBL] [Abstract][Full Text] [Related]
13. [Enoximone as pharmacologic "bridging" to heart transplantation].
Friedel N; Teebken M; Lemme A; Schüler S; Hetzer R
Z Kardiol; 1991; 80 Suppl 4():27-33. PubMed ID: 1833894
[TBL] [Abstract][Full Text] [Related]
14. [Role of the enoximone-dobutamine combination in the treatment of congestive cardiac insufficiency].
Richard C; Thuillez C; Annane D; Bellissant E; Teboul JL
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():33-7. PubMed ID: 2147832
[TBL] [Abstract][Full Text] [Related]
15. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
Installe E; De Coster P; Gonzalez M; Brichant C; Lessire H; Cauwe F
Eur Heart J; 1991 Sep; 12(9):985-93. PubMed ID: 1834466
[TBL] [Abstract][Full Text] [Related]
16. [Tolerance of enoximone in patients with heart failure].
Gilfrich HJ; Dieterich HA
Z Kardiol; 1991; 80 Suppl 4():93-7. PubMed ID: 1833904
[TBL] [Abstract][Full Text] [Related]
17. [New inotropic agents in the treatment of congestive heart failure].
Freitas M
Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
[TBL] [Abstract][Full Text] [Related]
18. Use of enoximone in patients awaiting cardiac transplant.
Bristow MR; Lee HE; Gilbert EM; Renlund DG; Hegewald MG; Hershberger RE; O'Connell JB
Br J Clin Pract Suppl; 1988 Dec; 64():69-72. PubMed ID: 2978503
[No Abstract] [Full Text] [Related]
19. Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure.
Shakar SF; Abraham WT; Gilbert EM; Robertson AD; Lowes BD; Zisman LS; Ferguson DA; Bristow MR
J Am Coll Cardiol; 1998 May; 31(6):1336-40. PubMed ID: 9581729
[TBL] [Abstract][Full Text] [Related]
20. [Enoximone and the therapeutic strategy in patients awaiting emergency cardiac graft].
Dubois-Randé JL; Loisance D; Duval-Moulin AM; Deleuze P; Lellouche D; Tavolaro O; Hittinger L; Benvenuti C; Merlet P; Brun D
Arch Mal Coeur Vaiss; 1989; 82(8):1433-8. PubMed ID: 2529834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
